Stocks
Amylyx Pharmaceuticals (AMLX) Operating Income US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| Operating Income, bln rub | -13.6 | -39.0 | -82.7 | -201.3 | 38.8 | -249.3 | ||
| Changes by years, y/y, % | +188% | +112% | +143% | -119% | ||||
Amylyx Pharmaceuticals. Operating Income, bln rub
Amylyx Pharmaceuticals. Operating Income, changes, %
Amylyx Pharmaceuticals. Operating Income, sum by quarters, bln rub
Amylyx Pharmaceuticals (AMLX) Operating Income US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Operating Income, bln rub | 18.7 | 1.93 | -122.1 | -53.4 | -75.7 | -249.3 | ||
| Changes by years, y/y, % | -134% | -104% | +5 849% | -365% | -504% | |||
| Changes by quarters, q/q, % | -7% | -90% | -6 415% | -56% | +42% | |||
